News

Viewing Page 1 of 1 | Showing Results 1 - 4 of 4

New immunotherapy studies for people with advanced melanoma

July 24, 2017

Two new studies of investigational and FDA-approved immunotherapies for advanced melanoma are opening soon at Providence Cancer Institute.

Genomics studies aim to improve targeted therapies

June 27, 2017

Two studies at Providence Cancer Institute are focusing on patients’ genomes to help identify the most effective targeted anti-cancer therapies.

Breast cancer research at Providence Cancer Center

May 27, 2016

Providence Cancer Center is currently enrolling patients in more than 20 studies investigating a broad spectrum of breast cancer therapies and interventions.

Breakthrough lung cancer drug helps clinical trial patient

March 06, 2015

A breakthrough drug for treating the most common type of lung cancer was just approved by the Food and Drug Administration ahead of schedule following two successful clinical trials, including one that involved patients at Providence Cancer Center in Portland.

Viewing Page 1 of 1 | Showing Results 1 - 4 of 4